Philip Morris International Inc. (PM) Stock Analysis
Latest ClaritX AI analysis ·
Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicotine. Its primary business involves both conventional cigarettes and an expanding array of smoke-free alternatives, such as innovative heat-not-burn devices, vapor products, and oral nicotine solutions. These offerings are distributed in markets worldwide, with the exception of the United States. The smoke-free portfolio includes brands like HEETS (encompassing Creations, Dimensions, Marlboro variants), Parliament HeatSticks, and TEREA, in additio
| Metric | Value |
|---|---|
| Price | $190.40 |
| Market cap | $296.8B |
| Sector | Consumer Defensive |
| Industry | Tobacco |
| ClaritX AI score | 92/100 |
| Price/Book | -34.67 |
| Dividend yield | 3.16% |
| Beta | 0.40 |
AI verdict
Philip Morris International Inc. (PM) stands as a premier, highly defensive compounding vehicle that is masterfully executing an industry-leading transformation into a high-margin, non-combustible consumer staples enterprise. The fundamental bedrock is virtually flawless, boasting an elite 67.51% gross margin, a world-class 26.30% ROIC, and $8.14 in per-share free cash flow. This immense cash generation effortlessly funds the newly announced, aggressive 8.8% dividend hike, bringing the annualized payout to $6.40. Furthermore, the monumental structural catalyst of the FDA intending to accelerate vape and pouch approvals directly supercharges the forward growth trajectory of PM's reduced-risk portfolio, radically widening its competitive moat against legacy tobacco peers who remain tethered to declining combustible volumes. Tactically, PM presents an exceptionally safe, asymmetric momentum profile for capital deployment. Trading at $190.40, the equity sits exactly $17.36, or 8.36%, below its absolute 52-week high of $207.76. This 8.36% discount provides a critical structural margin of safety, actively mitigating the severe risks associated with buying into euphoric, top-tick momentum, while still riding a confirmed secular uptrend above its 200-day SMA. This structural safety is exponentially magnified by the stock's ultra-low beta of 0.395, rendering it roughly 60.5% less volatile than the broader market. Supported by flawless Q2 insider buying metrics and massive dividend co
What this score has been worth
ClaritX scores PM 92 out of 100 (snapshot 2026-10-16).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 57 analyses that scored in the 90-100 band, the average forward return was -0.3% with a 51% win rate, -4.0pp against the S&P 500. That is a measured tendency across many names, not a forecast for PM — roughly 49% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.